RGBP – regen biopharma, inc. common (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

RGBP

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

9/23

08:26 am

rgbp

Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 [Yahoo! Finance]

Medium Report

Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 [Yahoo! Finance]

Report

9/23

08:00 am

rgbp

Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025

Neutral Report

Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025

Report

9/16

08:00 am

rgbp

Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate

High Report

Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.